NCT04679883View on ClinicalTrials.gov

Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease

PHASE2UnknownINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

January 30, 2022

Study Completion Date

April 30, 2022

Conditions
Dry Eye Syndromes
Interventions
DRUG

5% GLH8NDE

5% GLH8NDE as eye drops

DRUG

Placebo

Placebo as eye drops

Trial Locations (1)

06351

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

GL Pharm Tech Corporation

INDUSTRY